Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

C57BL/6 congenic mouse NRASQ61K melanoma cell lines are highly sensitive to the combination of Mek and Akt inhibitors in vitro and in vivo.

Petit V, Raymond J, Alberti C, Pouteaux M, Gallagher SJ, Nguyen MQ, Aplin AE, Delmas V, Larue L.

Pigment Cell Melanoma Res. 2019 Jun 28. doi: 10.1111/pcmr.12807. [Epub ahead of print]

PMID:
31251472
2.

Healthy but smaller herds: Predators reduce pathogen transmission in an amphibian assemblage.

Gallagher SJ, Tornabene BJ, DeBlieux TS, Pochini KM, Chislock MF, Compton ZA, Eiler LK, Verble KM, Hoverman JT.

J Anim Ecol. 2019 Jun 7. doi: 10.1111/1365-2656.13042. [Epub ahead of print]

PMID:
31175680
3.

Targeting DNA Methylation and EZH2 Activity to Overcome Melanoma Resistance to Immunotherapy.

Emran AA, Chatterjee A, Rodger EJ, Tiffen JC, Gallagher SJ, Eccles MR, Hersey P.

Trends Immunol. 2019 Apr;40(4):328-344. doi: 10.1016/j.it.2019.02.004. Epub 2019 Mar 7. Review.

4.

Marked Global DNA Hypomethylation Is Associated with Constitutive PD-L1 Expression in Melanoma.

Chatterjee A, Rodger EJ, Ahn A, Stockwell PA, Parry M, Motwani J, Gallagher SJ, Shklovskaya E, Tiffen J, Eccles MR, Hersey P.

iScience. 2018 Jun 29;4:312-325. doi: 10.1016/j.isci.2018.05.021. Epub 2018 Jun 28.

5.

SIRT6 haploinsufficiency induces BRAFV600E melanoma cell resistance to MAPK inhibitors via IGF signalling.

Strub T, Ghiraldini FG, Carcamo S, Li M, Wroblewska A, Singh R, Goldberg MS, Hasson D, Wang Z, Gallagher SJ, Hersey P, Ma'ayan A, Long GV, Scolyer RA, Brown B, Zheng B, Bernstein E.

Nat Commun. 2018 Aug 24;9(1):3440. doi: 10.1038/s41467-018-05966-z.

6.

Primary intracranial leiomyosarcoma in an immunocompetent patient: Case report and review of the literature.

Gallagher SJ, Rosenberg SA, Francis D, Salamat S, Howard SP, Kimple RJ.

Clin Neurol Neurosurg. 2018 Feb;165:76-80. doi: 10.1016/j.clineuro.2017.12.014. Epub 2018 Jan 6. Review.

PMID:
29324399
7.

Anti-PD-1-induced high-grade hepatitis associated with corticosteroid-resistant T cells: a case report.

McGuire HM, Shklovskaya E, Edwards J, Trevillian PR, McCaughan GW, Bertolino P, McKenzie C, Gourlay R, Gallagher SJ, Fazekas de St Groth B, Hersey P.

Cancer Immunol Immunother. 2018 Apr;67(4):563-573. doi: 10.1007/s00262-017-2107-7. Epub 2017 Dec 30.

8.

HDAC inhibitors restore BRAF-inhibitor sensitivity by altering PI3K and survival signalling in a subset of melanoma.

Gallagher SJ, Gunatilake D, Beaumont KA, Sharp DM, Tiffen JC, Heinemann A, Weninger W, Haass NK, Wilmott JS, Madore J, Ferguson PM, Rizos H, Hersey P.

Int J Cancer. 2018 May 1;142(9):1926-1937. doi: 10.1002/ijc.31199. Epub 2017 Dec 20.

9.

Patient-targeted Googling and social media: a cross-sectional study of senior medical students.

Chester AN, Walthert SE, Gallagher SJ, Anderson LC, Stitely ML.

BMC Med Ethics. 2017 Dec 4;18(1):70. doi: 10.1186/s12910-017-0230-9.

10.

Epigenetic modulation in cancer immunotherapy.

Gallagher SJ, Shklovskaya E, Hersey P.

Curr Opin Pharmacol. 2017 Aug;35:48-56. doi: 10.1016/j.coph.2017.05.006. Epub 2017 Jun 10. Review.

PMID:
28609681
11.

Australian shelf sediments reveal shifts in Miocene Southern Hemisphere westerlies.

Groeneveld J, Henderiks J, Renema W, McHugh CM, De Vleeschouwer D, Christensen BA, Fulthorpe CS, Reuning L, Gallagher SJ, Bogus K, Auer G, Ishiwa T; Expedition 356 Scientists.

Sci Adv. 2017 May 10;3(5):e1602567. doi: 10.1126/sciadv.1602567. eCollection 2017 May.

12.

Ssm1b expression and function in germ cells of adult mice and in early embryos.

Ratnam S, Bozek G, Martin T, Gallagher SJ, Payne CJ, Storb U.

Mol Reprod Dev. 2017 Jul;84(7):596-613. doi: 10.1002/mrd.22826. Epub 2017 Jun 5.

PMID:
28464323
13.

Low-frequency hearing preceded the evolution of giant body size and filter feeding in baleen whales.

Park T, Evans AR, Gallagher SJ, Fitzgerald EM.

Proc Biol Sci. 2017 Feb 8;284(1848). pii: 20162528. doi: 10.1098/rspb.2016.2528.

14.

New Miocene Fossils and the History of Penguins in Australia.

Park T, Fitzgerald EM, Gallagher SJ, Tomkins E, Allan T.

PLoS One. 2016 Apr 26;11(4):e0153915. doi: 10.1371/journal.pone.0153915. eCollection 2016.

15.

EZH2 as a mediator of treatment resistance in melanoma.

Tiffen JC, Gallagher SJ, Tseng HY, Filipp FV, Fazekas de St. Groth B, Hersey P.

Pigment Cell Melanoma Res. 2016 Sep;29(5):500-7. doi: 10.1111/pcmr.12481. Epub 2016 May 25. Review.

17.

A single-islet microplate assay to measure mouse and human islet insulin secretion.

Truchan NA, Brar HK, Gallagher SJ, Neuman JC, Kimple ME.

Islets. 2015;7(3):e1076607. doi: 10.1080/19382014.2015.1076607.

18.

Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy.

Gallagher SJ, Tiffen JC, Hersey P.

Cancers (Basel). 2015 Sep 25;7(4):1959-82. doi: 10.3390/cancers7040870. Review.

19.

Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes.

Tiffen JC, Gunatilake D, Gallagher SJ, Gowrishankar K, Heinemann A, Cullinane C, Dutton-Regester K, Pupo GM, Strbenac D, Yang JY, Madore J, Mann GJ, Hayward NK, McArthur GA, Filipp FV, Hersey P.

Oncotarget. 2015 Sep 29;6(29):27023-36. doi: 10.18632/oncotarget.4809.

20.

Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling.

Heinemann A, Cullinane C, De Paoli-Iseppi R, Wilmott JS, Gunatilake D, Madore J, Strbenac D, Yang JY, Gowrishankar K, Tiffen JC, Prinjha RK, Smithers N, McArthur GA, Hersey P, Gallagher SJ.

Oncotarget. 2015 Aug 28;6(25):21507-21.

21.

Inducible but not constitutive expression of PD-L1 in human melanoma cells is dependent on activation of NF-κB.

Gowrishankar K, Gunatilake D, Gallagher SJ, Tiffen J, Rizos H, Hersey P.

PLoS One. 2015 Apr 6;10(4):e0123410. doi: 10.1371/journal.pone.0123410. eCollection 2015.

22.

Control of NF-kB activity in human melanoma by bromodomain and extra-terminal protein inhibitor I-BET151.

Gallagher SJ, Mijatov B, Gunatilake D, Gowrishankar K, Tiffen J, James W, Jin L, Pupo G, Cullinane C, McArthur GA, Tummino PJ, Rizos H, Hersey P.

Pigment Cell Melanoma Res. 2014 Nov;27(6):1126-37. doi: 10.1111/pcmr.12282. Epub 2014 Jul 3.

PMID:
24924589
23.

EZH2: an emerging role in melanoma biology and strategies for targeted therapy.

Tiffen J, Gallagher SJ, Hersey P.

Pigment Cell Melanoma Res. 2015 Jan;28(1):21-30. doi: 10.1111/pcmr.12280. Epub 2014 Jun 27. Review.

PMID:
24912396
24.

The epigenetic regulator I-BET151 induces BIM-dependent apoptosis and cell cycle arrest of human melanoma cells.

Gallagher SJ, Mijatov B, Gunatilake D, Tiffen JC, Gowrishankar K, Jin L, Pupo GM, Cullinane C, Prinjha RK, Smithers N, McArthur GA, Rizos H, Hersey P.

J Invest Dermatol. 2014 Nov;134(11):2795-2805. doi: 10.1038/jid.2014.243. Epub 2014 Jun 6.

25.

Automated cell tracking and analysis in phase-contrast videos (iTrack4U): development of Java software based on combined mean-shift processes.

Cordelières FP, Petit V, Kumasaka M, Debeir O, Letort V, Gallagher SJ, Larue L.

PLoS One. 2013 Nov 27;8(11):e81266. doi: 10.1371/journal.pone.0081266. eCollection 2013.

26.

The BH3-mimetic ABT-737 sensitizes human melanoma cells to apoptosis induced by selective BRAF inhibitors but does not reverse acquired resistance.

Wroblewski D, Mijatov B, Mohana-Kumaran N, Lai F, Gallagher SJ, Haass NK, Zhang XD, Hersey P.

Carcinogenesis. 2013 Feb;34(2):237-47. doi: 10.1093/carcin/bgs330. Epub 2012 Oct 20.

PMID:
23087082
27.

Distinct requirements for Sin3a in perinatal male gonocytes and differentiating spermatogonia.

Gallagher SJ, Kofman AE, Huszar JM, Dannenberg JH, DePinho RA, Braun RE, Payne CJ.

Dev Biol. 2013 Jan 1;373(1):83-94. doi: 10.1016/j.ydbio.2012.10.009. Epub 2012 Oct 17.

28.

Beta-catenin inhibits melanocyte migration but induces melanoma metastasis.

Gallagher SJ, Rambow F, Kumasaka M, Champeval D, Bellacosa A, Delmas V, Larue L.

Oncogene. 2013 Apr 25;32(17):2230-8. doi: 10.1038/onc.2012.229. Epub 2012 Jun 4.

29.

General strategy to analyse coat colour phenotypes in mice.

Berlin I, Luciani F, Gallagher SJ, Rambow F, Conde-Perez A, Colombo S, Champeval D, Delmas V, Larue L.

Pigment Cell Melanoma Res. 2012 Jan;25(1):117-9. doi: 10.1111/j.1755-148X.2011.00912.x. Epub 2011 Nov 16. No abstract available.

PMID:
22085368
30.

General strategy to analyse melanoma in mice.

Gallagher SJ, Luciani F, Berlin I, Rambow F, Gros G, Champeval D, Delmas V, Larue L.

Pigment Cell Melanoma Res. 2011 Oct;24(5):987-8. doi: 10.1111/j.1755-148X.2011.00907.x. Epub 2011 Sep 29. No abstract available.

PMID:
21955491
31.

Sin3a is required by sertoli cells to establish a niche for undifferentiated spermatogonia, germ cell tumors, and spermatid elongation.

Payne CJ, Gallagher SJ, Foreman O, Dannenberg JH, Depinho RA, Braun RE.

Stem Cells. 2010 Aug;28(8):1424-34. doi: 10.1002/stem.464.

32.

Amino terminal hydrophobic import signals target the p14(ARF) tumor suppressor to the mitochondria.

Irvine M, Philipsz S, Frausto M, Mijatov B, Gallagher SJ, Fung C, Becker TM, Kefford RF, Rizos H.

Cell Cycle. 2010 Feb 15;9(4):829-39. Epub 2010 Mar 2.

PMID:
20107316
33.

p16INK4a expression and absence of activated B-RAF are independent predictors of chemosensitivity in melanoma tumors.

Gallagher SJ, Thompson JF, Indsto J, Scurr LL, Lett M, Gao BF, Dunleavey R, Mann GJ, Kefford RF, Rizos H.

Neoplasia. 2008 Nov;10(11):1231-9.

34.

Scope and limitations of the co-drug approach to topical drug delivery.

Lau WM, White AW, Gallagher SJ, Donaldson M, McNaughton G, Heard CM.

Curr Pharm Des. 2008;14(8):794-802. Review.

PMID:
18393881
35.

Glutamate receptor pathology is present in the hippocampus following repeated sub-lethal soman exposure in the absence of spatial memory deficits.

Johnson EA, Daugherty KS, Gallagher SJ, Moran AV, DeFord SM.

Neurotoxicology. 2008 Jan;29(1):73-80. Epub 2007 Sep 12.

PMID:
17942156
36.

The ARF tumour suppressor.

Gallagher SJ, Kefford RF, Rizos H.

Int J Biochem Cell Biol. 2006;38(10):1637-41. Epub 2006 Feb 28. Review.

PMID:
16600663
37.

Preferential pi-pi complexation between tamoxifen and borage oil/gamma linolenic acid: transcutaneous delivery and NMR spectral modulation.

Heard CM, Gallagher SJ, Congiatu C, Harwood J, Thomas CP, McGuigan C, Nemcová M, Nouskova T.

Int J Pharm. 2005 Sep 30;302(1-2):47-55.

PMID:
16115741
38.
39.

Inter- and intralaboratory variation of in vitro diffusion cell measurements: an international multicenter study using quasi-standardized methods and materials.

Chilcott RP, Barai N, Beezer AE, Brain SI, Brown MB, Bunge AL, Burgess SE, Cross S, Dalton CH, Dias M, Farinha A, Finnin BC, Gallagher SJ, Green DM, Gunt H, Gwyther RL, Heard CM, Jarvis CA, Kamiyama F, Kasting GB, Ley EE, Lim ST, McNaughton GS, Morris A, Nazemi MH, Pellett MA, Du Plessis J, Quan YS, Raghavan SL, Roberts M, Romonchuk W, Roper CS, Schenk D, Simonsen L, Simpson A, Traversa BD, Trottet L, Watkinson A, Wilkinson SC, Williams FM, Yamamoto A, Hadgraft J.

J Pharm Sci. 2005 Mar;94(3):632-8.

PMID:
15666298
40.

Web-based screening and brief intervention for hazardous drinking: a double-blind randomized controlled trial.

Kypri K, Saunders JB, Williams SM, McGee RO, Langley JD, Cashell-Smith ML, Gallagher SJ.

Addiction. 2004 Nov;99(11):1410-7.

PMID:
15500594
41.

An internet-based survey method for college student drinking research.

Kypri K, Gallagher SJ, Cashell-Smith ML.

Drug Alcohol Depend. 2004 Oct 5;76(1):45-53.

PMID:
15380288
42.

Effects of membrane type and liquid/liquid phase boundary on in vitro release of ketoprofen from gel formulations.

Gallagher SJ, Trottet L, Carter TP, Heard CM.

J Drug Target. 2003 Jul;11(6):373-9.

PMID:
14668058
43.

Ketoprofen: release from, permeation across and rheology of simple gel formulations that simulate increasing dryness.

Gallagher SJ, Trottet L, Heard CM.

Int J Pharm. 2003 Dec 11;268(1-2):37-45.

PMID:
14643975
44.

Acceptability of various brief intervention approaches for hazardous drinking among university students.

Kypri K, Saunders JB, Gallagher SJ.

Alcohol Alcohol. 2003 Nov-Dec;38(6):626-8.

PMID:
14633653
45.

Medical management of hypercalcemia.

Ralston SH, Coleman R, Fraser WD, Gallagher SJ, Hosking DJ, Iqbal JS, McCloskey E, Sampson D.

Calcif Tissue Int. 2004 Jan;74(1):1-11. Epub 2003 Oct 6. Review. No abstract available.

PMID:
14523593
46.

Effects of tamoxifen on ischemia-induced angiogenesis in the mouse lung.

Wagner EM, Gallagher SJ, Reddy S, Mitzner W.

Angiogenesis. 2003;6(1):65-71.

PMID:
14517406
47.

Incentives to increase participation in an Internet survey of alcohol use: a controlled experiment.

Kypri K, Gallagher SJ.

Alcohol Alcohol. 2003 Sep-Oct;38(5):437-41.

PMID:
12915520
49.

Human mast cells induce caspase-independent DNA fragmentation in leukemic T cells.

Gallagher SJ, Marshall JS, Hoskin DW.

Oncol Rep. 2003 Jul-Aug;10(4):1019-23.

PMID:
12792763
50.

Identification of genes promoting angiogenesis in mouse lung by transcriptional profiling.

Srisuma S, Biswal SS, Mitzner WA, Gallagher SJ, Mai KH, Wagner EM.

Am J Respir Cell Mol Biol. 2003 Aug;29(2):172-9. Epub 2003 Feb 14.

PMID:
12600816

Supplemental Content

Loading ...
Support Center